The global cervical cancer diagnostic tests market is witnessing steady growth, supported by rising awareness of early cancer detection, increasing screening participation, and advancements in diagnostic technologies. Valued at US$ 5.4 billion in 2025, the market is projected to reach US$ 9.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036....
